Ex­clu­sive: Af­ter win­ning le­gal bat­tle, for­mer Phase­Bio in­vestor finds US buy­er for its PhI­II drug to re­verse Bril­in­ta

Hav­ing wran­gled con­trol of a blood thin­ner re­ver­sal agent, SFJ Phar­ma has found a buy­er for the drug.

SERB Phar­ma­ceu­ti­cals, a spe­cial­ty phar­ma that vast­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER